Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
BioDelivery Sciences International Inc, Medical Devices Deals, 2011 to YTD 2017 10
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
BioDelivery Sciences Enters into Co-Development Agreement with Evonik 12
Licensing Agreements 13
Purdue Pharma (Canada) Enters into Licensing Agreement with BioDelivery Sciences International 13
Collegium Pharma Enters into Licensing Agreement with BioDelivery Sciences International 14
BioDelivery Sciences Enters Into Licensing Agreement With Arcion For Topical Clonidine Gel 15
Equity Offering 17
BioDelivery Sciences Completes Private Placement Of Shares For US$60 Million 17
BioDelivery Sciences Completes Public Offering Of Common Stock And Prferred Stock For US$40 Million 18
BioDelivery Sciences International Completes Private Placement Of US$15 Million 20
BioDelivery Sciences International Inc – Key Competitors 21
BioDelivery Sciences International Inc – Key Employees 22
BioDelivery Sciences International Inc – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Financial Announcements 24
Nov 09, 2017: BioDelivery Sciences Reports Third Quarter 2017 Financial Results and Provides Corporate Update 24
Aug 09, 2017: BioDelivery Sciences Reports Second Quarter 2017 Financial Results and Provides Corporate Update 26
May 15, 2017: BioDelivery Sciences Reports First Quarter 2017 Financial Results and Provides Corporate Update 28
Mar 17, 2017: BioDelivery Sciences Provides Corporate Update and Reports Fourth Quarter and Full-Year 2016 Financial Results 30
Nov 09, 2016: BioDelivery Sciences Provides Corporate Update and Reports Third Quarter 2016 Financial Results 33
Aug 09, 2016: BioDelivery Sciences Provides Corporate Update and Reports Second Quarter 2016 Financial Results 35
May 10, 2016: BioDelivery Sciences Provides Corporate Update and Reports First Quarter 2016 Financial Results 38
Mar 10, 2016: BioDelivery Sciences Provides Corporate Update and Reports Fourth Quarter and Full-Year 2015 Financial Results 40
Corporate Communications 42
Aug 23, 2017: BioDelivery Sciences President and Chief Executive Officer Dr. Mark A. Sirgo to Retire at Year-End While Continuing as Vice Chairman 42
Oct 05, 2016: BioDelivery Sciences Announces Additions to its Board of Directors 43
Product News 44
09/30/2016: BioDelivery Sciences Cites Impressive Number of Physicians Granted Waiver to Increase Patient Limit for Opioid Dependence Treatment Following Recent HHS Rule 44
03/04/2016: BioDelivery Sciences to provide an update on BELBUCA (buprenorphine) at the Cowen And Company 36th Annual Healthcare Conference and the 28th Annual Roth Conference 45
03/04/2016: BioDelivery Sciences to provide an update on Buprenorphine Injection at the Cowen And Company 36th Annual Healthcare Conference and the 28th Annual Roth Conference 46
02/22/2016: BioDelivery Sciences Announces the Launch of BELBUCA (Buprenorphine) Buccal Film by Endo Pharmaceuticals for Chronic Pain Management 47
Clinical Trials 48
Jun 03, 2016: New Data Demonstrate Safety Of Long-Term, Around-The-Clock Treatment With BELBUCA (Buprenorphine) Buccal Film For Chronic Pain 48
Appendix 49
Methodology 49
About GlobalData 49
Contact Us 49
Disclaimer 49
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
BioDelivery Sciences International Inc, Deals By Therapy Area, 2011 to YTD 2017 9
BioDelivery Sciences International Inc, Medical Devices Deals, 2011 to YTD 2017 10
BioDelivery Sciences International Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
BioDelivery Sciences Enters into Co-Development Agreement with Evonik 12
Purdue Pharma (Canada) Enters into Licensing Agreement with BioDelivery Sciences International 13
Collegium Pharma Enters into Licensing Agreement with BioDelivery Sciences International 14
BioDelivery Sciences Enters Into Licensing Agreement With Arcion For Topical Clonidine Gel 15
BioDelivery Sciences Completes Private Placement Of Shares For US$60 Million 17
BioDelivery Sciences Completes Public Offering Of Common Stock And Prferred Stock For US$40 Million 18
BioDelivery Sciences International Completes Private Placement Of US$15 Million 20
BioDelivery Sciences International Inc, Key Competitors 21
BioDelivery Sciences International Inc, Key Employees 22
BioDelivery Sciences International Inc, Subsidiaries 23